ArticleJournal of patient-reported outcomes2025
The impact of vitreous floaters on quality of life: a qualitative study.
Article in Journal of patient-reported outcomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Multimedia health education to alleviate anxiety in patients with vitreous floaters.Frontiers in public health · 2026Trial
- Clinical characteristics and treatment willingness of outpatients with vitreous floaters: a real-world study in China.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Using patient input to develop item banks to measure quality-of-life impact of vitreous floaters.BMJ open ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundIn this study we explore the quality-of-life impact of vitreous floaters, and identify all possible issues that may be relevant to a person experiencing floaters, with the aim to define the content of a floaters-specific patient-reported outcome measure, which can help determine the disease burden and benefit of treatment for a patient with floaters. METHODOLOGY: Semi-structured telephone interviews were conducted with patients with floaters. The topic guide was based on an extensive literature review and expert opinion. Interview transcripts were coded into all possible quality-of-life issues that may be relevant to a person experiencing floaters. We grouped these into quality-of-life domains and subdomains, using an earlier framework of quality of life in other ophthalmic diseases.
resultsWe categorized the patients’ reports (N = 44) into 11 quality-of-life domains: activity limitations, visual symptoms, ocular symptoms, general symptoms, health concerns, emotional well-being, social well-being, mobility issues, economic impact, inconveniences, and the need to use coping strategies.
conclusionsVitreous floaters result in specific quality-of-life issues that have not been adequately measured with previous patient-reported outcome measures. When compared to other eye conditions, three previously unidentified issues stand out among patients with floaters: the effects of different lighting conditions, intermittent vision impairment caused by eye movements, and the importance of seeking understanding and support from healthcare providers. Eye care clinicians should recognize these issues when evaluating patients with floaters. The present patient-driven determination of relevant quality-of-life issues can guide initiatives in floaters-specific patient-reported outcome measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.